ERNA:Ernexa Therapeutics Inc * Snapshot | Charting | News | Options
*Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
$6.04   0.00%  $0.00 NASDAQ 8:33a ET
May 6 '26 		Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete... GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models
     GlobeNewswire
    Full Story →

    Headline News
    Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split
    8:59a ET April 30 '26 GlobeNewswire
    Ernexa Therapeutics Highlights Key Catalysts as Company Advances Toward First-in-Human Clinical Trials in 2026
    8:55a ET March 31 '26 GlobeNewswire
    Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
    9:05a ET February 20 '26 GlobeNewswire
    More News →
    Day  0.00%Week  63.7%Month  12.9%More Charting →
    May 6 '26. Markets Closed.
    Last $6.04
    Day change   0.00%$0.00
    Open $NA
    Gap at open $NA
    Previous close $6.04
    Trading volume 149,567
    10 Day avg vol. 6,442,506
    Shares out. 1.2Mil
    Market cap. $7.0Mil
    Trading activity Below Avg.
    Previous data from yesterday, May 6 '26.

    Historical Price Performance
    3 month   35.80% 
    6 month   86.19% 
    1 year   92.22% 
    2 year   99.19% 

    Earnings
    Previous 12m -$81.17
    Next 12m Estimate NM
    P/E ratio --
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2026 All rights reserved.